Pregled bibliografske jedinice broj: 1253088
Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report
Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report // Frontiers in pharmacology, 12 (2021), 684537, 11 doi:10.3389/fphar.2021.684537 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1253088 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Beneficial Treatment Outcomes of Severe COVID-19
Patients Treated Entirely in Primary Care Settings
With Dexamethasone Including Regimen—Case Series
Report
Autori
Vukoja, Damir ; Jurić, Andrea ; Erkapić, Zdravka ; Pejić, Tomislav ; Zovko, Željko ; Juričić, Josipa ; Pejić, Jelena ; Ćorluka, Matea
Izvornik
Frontiers in pharmacology (1663-9812) 12
(2021);
684537, 11
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
COVID-19 ; SARS-CoV-2 ; coronavirus ; corticosteroids ; dexamethasone ; primary health care ; treatment
Sažetak
Even in 2021, coronavirus disease 2019 (COVID-19) remains a major global health concern, especially in developing countries. The burden of this disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which affects not only primary respiratory but also other organ systems, keeps rising as the pandemic continues. Primary health care centers are the first line where COVID-19 patients are managed and should be able to manage the vast majority of them successfully. In this paper, we present a case series and concept of beneficial management of even deteriorating and severe patients treated entirely in our primary health center. The management is based on well-timed and rational dexamethasone use, as well as on various other pharmacological and nonpharmacological treatments and interventions, and is supported by provided statistical data. According to the presented experience and positive outcomes achieved, it seems that even deteriorating and severe COVID-19 patients can be treated successfully to some extent or even completely in primary care settings. This kind of approach could be particularly beneficial in conditions of overload of higher-level health care institutions.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Poveznice na cjeloviti tekst rada:
Pristup cjelovitom tekstu rada doi www.frontiersin.org pubmed.ncbi.nlm.nih.govCitiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus